期刊文献+

农村地区妇女乳腺癌筛检对象及时间探讨 被引量:1

下载PDF
导出
摘要 我国乳腺癌的发病率正随着经济的发展而急速上升,农村妇女乳腺癌发病年平均增长率(6.3%)高于城市妇女(3.9%)。通过筛检可以早期发现乳腺癌,既能提高治愈率,又能保持高生活质量并节约医疗资源。本次研究通过探讨农村地区妇女乳腺癌的筛检年龄段及筛检的间隔时间。报道如下。
出处 《全科医学临床与教育》 2013年第3期318-319,共2页 Clinical Education of General Practice
  • 相关文献

参考文献6

二级参考文献45

  • 1才玉忠,于学智,傅荣湛,顾禾.青、老年人乳腺癌淋巴结转移规律的分析[J].癌症,1994,13(4):357-358. 被引量:3
  • 2杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 3Sun C X, Robb V A, Gutmann D H. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation[J]. J Cell Sci, 2002,115(21): 3991-4000. 被引量:1
  • 4Terawaki S I, Kitano K, Hakoshima T. Structural basis for type Ⅱ membrane protein binding by ERM proteins revealed by the radixin-neutral endopeptidase 24.11 (NEP) complex[J]. J Biol Chem, 2007, 282(27): 19854-19862. 被引量:1
  • 5Pujuguet P, Del Maestro L, Gautreau A, et al. Ezrin regulates E cadherin-dependent adherens junction assembly through racl activation[J]. Mol Biol Cell, 2003, 4(5) :2181-2191. 被引量:1
  • 6Mathieu A, Saal I, Vuckovic A, et al. Nuclear galectin-3 expression is an independent predictive factor of recurrence for adenocarcinoma and squamous cell carcinoma of the lung[J]. Mod Pathol, 2005,18(9): 1264-1271. 被引量:1
  • 7Moilanen J, Lassus H, Leminen A, et al. Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients[J].Gynecol Oneol, 2003,90 (2) : 273-281. 被引量:1
  • 8Zeng H, Xu L, Xiao D, et al. Altered expression of ezrin in esophageal squamous cell carcinoma[J].J Histochem Cytochem, 2006, 54(8) :889-896. 被引量:1
  • 9Elliott B E, Meens J A, SenGupta S K, et al. The membrane cytoskeletal crosslinker Ezrin is required for metastasis of breast carcinoma cells[J]. Breast Cancer Res, 2005, 7(3):365-373. 被引量:1
  • 10Orian-Rousseau V, Morrison H, Matzke A, et al. Hepatocyte growth factor induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin[J].Mol Biol Cell, 2007, 18(1): 76-83. 被引量:1

共引文献187

同被引文献23

  • 1王国蓉,蒋晓莲,王利萍.乳腺癌病人就医延迟现状及干预研究[J].护理研究(上旬版),2007,21(8):1979-1981. 被引量:5
  • 2Huo Q, Cai C, Zhang Y, et al. Delay in diagnosis and treatment of symptomatic breast cancer in China[J].Ann Surg Oncol, 2015, 22(3):883-888. 被引量:1
  • 3Hoffman HJ, Khan A, Ajmera KM, et al. Initial re- sponse to chemotherapy, not delay in diagnosis, predicts overall survival in inflammatory breast cancer cases[J].Am J Clin Oncol, 2014, 37(4):315-321. 被引量:1
  • 4Partridge AH, Hughes ME, Ottesen RA, et al. The ef- fect of age on delay in diagnosis and stage of breast cancer[J].Oncologist, 2012, 17(6):775-782. 被引量:1
  • 5Otieno ES,Micheni JN,Kimende SK,et al. Provider delay in the diagnosis and initiation of definitive treatment for breast cancer patients[J]. East Afr Med J,2010,87(4): 143-146. 被引量:1
  • 6Ermiah E,Abdalla F,Buhmeida A,et al. Diagnosis delay in Libyan female breast cancer[J].BMC Res Notes,2012, 16(5 ):452-456. 被引量:1
  • 7Richards FM,McKee SA,Rajpar MH,et al. Germline E- cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer[J]. Human Molecular Genetic s, 1999,8 ( 4 ):607-610. 被引量:1
  • 8Schmidt-Hansen M,Taubert M,Bromham N,et al. The effectiveness of buprenorphine for treating cancer pain: an abridged Cochrane review[J]. BMJ supportive & pal- liative care,2015. 被引量:1
  • 9DueU EJ,Lujan-Barroso L,Llivina C,et al. Vitamin C transporter gene (SLC23A1 and SLC23A2)polymorphisms,plasma vitamin C levels,and gastric cancer risk in the EPIC cohort[J]. Genes & nutrition,2013,8(6):549-560. 被引量:1
  • 10Abu-Helalah AM,Alshraideh AH,A1-Hanaqtah M,et al. Delay in presentation,diagnosis,and treatment for breast cancer patients in jordan[J]. Breast J,2016,22 (2):213- 217. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部